Rebecca Rosberg
banner
rebeccarosberg.bsky.social
Rebecca Rosberg
@rebeccarosberg.bsky.social
🧠 PhD Student @pietraslab in Brain Tumor Biology, Lund University. Interested in #Tumor #Microenvironment🩸 Cancer Survivor from Acute Leukemia🎗️ #APML
Reposted by Rebecca Rosberg
📣 Preprint alert! Happy to share our latest work, in which we identify Flunarizine as an inhibitor of astrocyte reactivity with therapeutic potential in glioblastoma (GBM). Details in 🧵:
www.biorxiv.org/content/10.1...
Phenotypic Screening Identifies Flunarizine as an Inhibitor of Radiotherapy-Induced Astrocyte Reactivity with Therapeutic Potential in Glioblastoma
Radiotherapy is part of the standard-of-care for glioblastoma, yet tumors invariably recur as incurable lesions post-treatment. Recent studies suggest that radiation-induced astrocyte reactivity foste...
www.biorxiv.org
July 18, 2025 at 7:01 AM
Reposted by Rebecca Rosberg
🚨 We’re hiring a bioinformatics-focused PhD student for our ERC-funded project on recurrent GBM! Focus: tumor-supportive microenvironment 🔬 Experience with scRNA-seq, spatial transcriptomics & Python/R a plus. Must be self-motivated & driven. DM for details! Repost=❤️ lu.varbi.com/en/what:job/...
Doctoral Student in Tumor Biology
Description of the workplace The research group conducts experimental research on brain tumors and is led by Associate Professor Alexander Pietras. The group consists of a bioinformatician, two postdo
lu.varbi.com
May 15, 2025 at 8:27 AM
Reposted by Rebecca Rosberg
And here's @rebeccarosberg.bsky.social (with others) accepting her poster prize to conclude a wonderful symposium in Paris 🤩🔥🧠🇫🇷
January 31, 2025 at 3:15 PM
Reposted by Rebecca Rosberg
At the Brain Tumor Microenvironment Symposium @institutducerveau.bsky.social, Sebastian Braun presented our comprehensive study of pericytes in GBM 🤩. Pericytes act as guardians of the peri-vascular niche to prevent malignant cell invasion, read more at www.biorxiv.org/content/10.1...
January 31, 2025 at 12:40 PM
Reposted by Rebecca Rosberg
...and here's Karolina Smolag @karolinasmolag.bsky.social delivering the second Pietras lab talk of the day 🤩 We also have a couple of posters so please check them out if you're with us in Paris!
January 30, 2025 at 2:42 PM
Reposted by Rebecca Rosberg
We're excited to be at the Institute du Cerveau in Paris for the brain tumor microenvironment symposium 🧠 Here's Pauline Jeannot with the first presentation of the day from the lab 🔥
January 30, 2025 at 11:30 AM
Reposted by Rebecca Rosberg
A new mechanism reveals how Tregs are sustained in the glioma microenvironment, negatively impacting patient survival

🎉 Thrilled to share our latest paper from Anna Blom's lab in collaboration with @pietraslab.bsky.social

Full story in Cancer Immunology Research: aacrjournals.org/cancerimmuno...
November 26, 2024 at 7:26 PM
Reposted by Rebecca Rosberg
Meet our PhD student Rebecca! This year, she beat cancer AND published her first 1st-author paper on how hypoxia induces complement signaling in GBM, alters macrophage polarization, and how the C3-C3AR1 axis can be therapeutically targeted in GBM models. Check it out! insight.jci.org/articles/vie...
November 19, 2024 at 12:59 PM
Reposted by Rebecca Rosberg
Inspired by the other amazing starter packs - here's one for cancer researchers!

I tried to make this broad - from immunology to genomics to cell biology and so much more..

This list also includes organizations & institutes supporting cancer researchers 🧪🔬⚕️🩺

Hope its useful!

go.bsky.app/FEoaJMc
November 14, 2024 at 9:44 PM
Hi Blue! Sharing my personal journey as a cancer researcher & cancer patient. Exploring the beauty of tumor complexity and getting a first-hand view into how therapy can change the outcome of patient lives.
November 19, 2024 at 12:40 PM
Reposted by Rebecca Rosberg
We love to explore unexpected findings 🤔 Check out our two latest studies detailing the unexplored expression of ALK1 in immunosuppressive macrophages and the critical role of pericytes as a paracrine signaling hub in GBM.
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
November 18, 2024 at 11:11 AM